Moderna, Inc.

NASDAQ:MRNA

34.62 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 9661,8552411672,8131,8313441,8625,0843,2204,5665,9406,9494,8294,2151,743229.37512.21628.4424.45710.55313.33810.0314.11532.81636.66225.83127.4688.41642.47335.72435.724
Cost of Revenue 7395141561329292,2417317921,9181,1001,3811,0179527227501937.933344152115117.954119.637128.305130.413150.429109.05104.47990.124117.82793.61399.5199.51
Gross Profit 2271,34185351,884-410-3871,0703,1662,1203,1854,9235,9974,1073,4651,550221.442-331.784-123.558-110.543-107.401-106.299-118.275-116.298-117.613-72.388-78.648-62.664-29.411-51.14-63.786-63.786
Gross Profit Ratio 0.2350.7230.3530.210.67-0.224-1.1250.5750.6230.6580.6980.8290.8630.850.8220.8890.965-27.16-4.344-24.802-10.177-7.97-11.792-8.239-3.584-1.974-3.045-2.282-0.333-1.204-1.786-1.786
Reseach & Development Expenses 1,1221,1371,1801,0271,4061,1601,1481,1311,211820710554648521421401758.86344.486151.856115.137118.754119.715128.496130.575150.429109.05104.47990.124117.82793.61399.5199.51
General & Administrative Expenses 0000266000254000000078.9948.54136.62224.11425.85728.18828.52327.28338.02318.52521.38716.31715.90516.7316.04416.044
Selling & Marketing Expenses 000020400012100000000000000000000000
SG&A 3512812682744704423323053752782112682011681217778.9948.54136.62224.11425.85728.18828.52327.28338.02318.52521.38716.31715.90516.7316.04416.044
Other Expenses 0-7-200200065-144-183-126-262-140-139-194-341.37-145-38-4-1.837-3.708-1.764-0.2870-5.095-0.337-0.214-3.488-93.613-99.51-99.51
Operating Expenses 1,4731,4111,4481,3011,8781,6021,4801,4361,586954738696587549403284496.48247.333150.569135.319141.109144.195153.966155.948185.847122.48122.846104.862130.24417.72616.39716.397
Operating Income -1,246-70-1,363-1,2666-2,012-1,867-3661,5801,1662,4474,2275,4103,5583,0621,266-275.038-235.117-122.127-130.862-130.556-130.857-143.936-141.833-153.031-85.818-97.015-77.402-41.828-67.87-79.829-79.829
Operating Income Ratio -1.29-0.038-5.656-7.5810.002-1.099-5.427-0.1970.3110.3620.5360.7120.7790.7370.7260.726-1.199-19.247-4.294-29.361-12.371-9.811-14.351-10.048-4.663-2.341-3.756-2.819-0.473-1.598-2.235-2.235
Total Other Income Expenses Net 62918410164541186175512720-61-64.0262.3455.5626.6985.8097.4858.5589.23311.7735.4876.5725.0263.7133.0853.2813.281
Income Before Tax -1,18421-1,279-1,16570-1,958-1,749-3051,6551,2172,4744,2295,4103,5523,0631,260-271.012-232.772-116.565-124.164-124.409-123.372-135.378-131.148-141.258-80.331-90.443-72.376-38.115-64.785-76.548-76.548
Income Before Tax Ratio -1.2260.011-5.307-6.9760.025-1.069-5.084-0.1640.3260.3780.5420.7120.7790.7360.7270.723-1.182-19.055-4.098-27.858-11.789-9.25-13.497-9.291-4.305-2.191-3.501-2.636-0.431-1.525-2.143-2.143
Income Tax Expense -648010-1471,672-369-384190174277572542219283391.4730.8640.1480.066-0.169-0.178-0.324-0.0240.1681.2350.158-0.187-0.1710.0020.0470.047
Net Income -1,12013-1,279-1,175217-3,630-1,380791,4651,0432,1973,6574,8683,3332,7801,221-272.485-233.636-116.713-124.23-124.24-123.194-135.054-131.124-141.426-80.331-90.601-72.376-37.944-68.264-80.076-80.076
Net Income Ratio -1.1590.007-5.307-7.0360.077-1.983-4.0120.0420.2880.3240.4810.6160.7010.690.660.701-1.188-19.125-4.104-27.873-11.773-9.236-13.465-9.29-4.31-2.191-3.507-2.636-0.429-1.607-2.242-2.242
EPS -2.910.034-3.33-3.080.57-9.53-3.620.23.812.535.248.5812.038.276.933.05-0.69-0.59-0.31-0.35-0.37-0.37-0.41-0.4-0.43-0.25-0.23-0.18-0.13-1.05-1.25-1.25
EPS Diluted -2.910.033-3.33-3.080.55-9.53-3.620.23.622.535.248.5811.297.76.462.84-0.69-0.59-0.31-0.35-0.37-0.37-0.41-0.4-0.43-0.25-0.23-0.18-0.13-1.05-1.25-1.25
EBITDA -1,11879-1,232-1,123208-1,699-1,646-2181,6601,2792,5234,3065,4883,6263,1371,278-259.798-221.438-107.087-115.049-113.475-114.529-126.337-123.82-145.681-73.85-84.592-67.196-35.913-62.74-75.083-75.083
EBITDA Ratio -1.1570.043-5.485-7.3650.107-0.963-5.16-0.1550.3110.4170.5360.7270.7790.7510.7440.733-1.199-19.247-4.294-25.885-12.371-8.595-14.351-10.048-4.663-1.994-3.293-2.449-0.406-1.477-2.102-2.102